Runaway “mental illness” fraud gallops on at an ever increasing pace. The latest example of this fraud that I’ve seen is in this comparative study, reported on by Reuters, under the heading, Fewer minority kids diagnosed with ADHD.
Black and Hispanic children are half as likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) as their white peers, according to a new study that followed U.S. kindergarteners through middle school.
You’d think that would be good news, right? Think again.
“It’s a consistent pattern of what we’re interpreting as comparative underdiagnosis for minority populations,” he (study leader Paul Morgan) told Reuters Health.
If we’re diagnosing more white kids with ADHD than we are black and hispanic, it’s not because we’re overdiagnosing it in white kids, it’s because we’re underdiagnosing it in black and hispanic kids.
Let me tell you, illogic like that is not going to reduce the overall “mental illness” rate in the world today one iota. If anything, it’s likely to increase it.
“If you’ve got certain groups of kids with a disorder who are not being picked up … they might not be accessing treatment that can help in terms of their school-based functioning,” he said. That, in turn, can lead to poor self-esteem and acting out.
Morgan then goes on to talk about the dangers of “untreated ADHD”. The short list he gives includes anxiety (a disease according to the gospel of the APA), depression (ditto) and “substance abuse”, sometimes euphemistically termed “self-medicating.”
Just what we needed, huh? More ‘mental ill health’ in the world.
This study is not about benefiting the minority community. How is the minority community going to benefit from a larger population of people with “mental illness” labels within it? This comparative study is about selling mental health treatment, and with it, “mental illness”. There is basically one form of treatment used in standard practice these days. That one form of treatment is the use of psychotropic drugs. The one group that stands to benefit from such a study is comprised of multi-national drug companies.
Excuse me. I was a little rash in my last statement. Two groups actually stand to benefit. Were we to impose equality of disease diagnosis, by increasing the rate of diagnosis in minority communities, the overall “mental illness” rate goes up. The two groups that stand to benefit would be “mental health” professionals who would then have greater job security, and the drug industry that would have an increasing profit margin. Everybody else loses.
Children with ADHD diagnoses, as Morgan pointed out, are also prone to be diagnosed anxious, depressed, and to take illicit drugs. Short list. We really need a lot more of that in this country. Oh, yeah!
I don’t see much upward mobility for minorities developing out of this predicament, instead I see a persistent downward slide. This sort of equality–equality in disease diagnosis rates–is much like equality of inopportunity, and equality of inopportunity is just the sort of equality we don’t need.
Filed under: Advertising, Biological Psychiatry, Children and Adolescents, Conflict of Interest, Discrimination, Fraud, Misdiagnosis, Pharmaceutical Company, Polypharmacy, Psychiatric Drugs | Tagged: attention deficit hyperactivity, attention deficit hyperactivity disorder adhd, mental health treatment, mental ill health, research |